Insight Brief
Southeast Asia and Pakistan Overview: The Emerging Hub for Clinical Trial Scale Up
How these emerging markets support efficient patient recruitment and create vast opportunities to accelerate trial growth and innovation across multiple therapeutic areas.
Mar 27, 2026
Southeast Asia and Pakistan represent competitive regions for clinical development, combining large, diverse populations with improving healthcare infrastructure. These markets enable efficient patient recruitment and create vast opportunities to accelerate trial growth and innovation across multiple therapeutic areas.
Proactive shift in regulatory frameworks, a maturing clinical trial ecosystem, and strategic national initiatives position this geography as a key hub for global research.